A chalcone derivative, 1m‐6, exhibits atheroprotective effects by increasing cholesterol efflux and reducing inflammation‐induced endothelial dysfunction

Liv Weichien Chen,Min‐Chien Tsai,Ching‐Yuh Chern,Tien‐Ping Tsao,Feng‐Yen Lin,Sy‐Jou Chen,Pi‐Fen Tsui,Yao‐Wen Liu,Hsien‐Jui Lu,Wan‐Lin Wu,Wei‐Shiang Lin,Chien‐Sung Tsai,Chin‐Sheng Lin
DOI: https://doi.org/10.1111/bph.15175
IF: 7.3
2020-07-20
British Journal of Pharmacology
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3><p>Atherosclerosis, resulting from lipid dysregulation and vascular inflammation, causes atherosclerotic cardiovascular disease (ASCVD), which contributes to morbidity and mortality worldwide. Chalcone and its derivatives possess several beneficial properties, including anti‐inflammatory, antioxidant, and antitumor activity with unknown cardioprotective effects. We aimed to develop an effective chalcone derivative with antiatherogenic potential.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3><p>Human THP‐1 cells and HUVECs were used as <i>in vitro </i> models. Western blots and real‐time PCRs were performed to quantify protein, mRNA, and miRNA expressions. The cholesterol efflux capacity was assayed by <sup>3</sup>H labelling of cholesterol. <i>Ldlr </i><sup><i>‐/‐ </i></sup> mice fed a high‐fat diet were used as an <i>in vivo </i> atherogenesis model. Haematoxylin and eosin and oil red O staining were used to analyse plaque formation. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3><p>We screened the effects on ABCA1 expression, and identified the chalcone derivative, 1m‐6, which enhances ABCA1 expression and promotes cholesterol efflux in THP‐1 macrophages. Moreover, 1m‐6 stabilizes <i>ABCA1 </i> mRNA and suppresses the expression of potential ABCA1‐regulating miRNAs through Nrf2/HO‐1 signaling. Additionally, 1m‐6 significantly inhibits TNF‐α‐induced expression of adhesion molecules, VCAM‐1 and ICAM‐1, and production of proinflammatory cytokines via inhibition of JAK/STAT3 activation and the modulation of Nrf2/HO‐1 signaling in HUVECs. In atherosclerosis‐prone mice, treatment with 1m‐6 significantly reduces lipid accumulation and atherosclerotic plaque formation. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3><p>Our study demonstrates that 1m‐6 produces promising atheroprotective effects by enhancing cholesterol efflux and suppressing inflammation‐induced endothelial dysfunction, which opens a new avenue for treating ASCVD.</p></section>
pharmacology & pharmacy
What problem does this paper attempt to address?